作者进行了两次预期性研究。对108例患者确诊后(诊断性活检阳性或临床表现加结素试验阳性)随机以2HRS+16HR 和2SHE+16HE 进行治疗,每月检查1次至3个月,此后3个月复查1次至3年。化疗结束时65%肿大的淋巴结炎症消散,表面光滑平整。化疗期间12%又新发现淋巴结,13%仍存在淋巴结肿大,11%发生软化波动,7%溃烂排脓,19%施行切除术或抽吸术。化疗结束时2%出现窦道持续排脓或疤痕未愈,但18个月后愈合,13%遗留残余的淋 The author conducted two prospective studies. After 108 patients were diagnosed (positive for diagnostic biopsy or clinical manifestations plus positive tuberculin test) were randomly treated with 2HRS + 16HR and 2SHE + 16HE, once per month for 3 to 3 months and then for 1 to 3 months 3 years. Chemotherapy at the end of 65% swollen lymph node inflammation dissipated, the surface smooth. 12% of new lymph nodes were found during chemotherapy, 13% still had lymphadenopathy, 11% softened, 7% ulcerated, and 19% resection or aspiration. At the end of chemotherapy, 2% of the sinus continued to drain or scar healed, but healed after 18 months, leaving 13% residual leftover